New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2014
09:35 EDTPODDInsulet price target raised to $43 from $35 at Stephens
Stephens raised its price target on Insulet to $43 following the company's Q4 report and FY14 guidance, but says it views the shares as fairly valued and maintains its Equal Weight rating on the stock.
News For PODD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
09:20 EDTPODDInsulet weakness creates buying opportunity, says Wedbush
Wedbush believes that Insulet's growth should accelerate as the year progresses, driven by increased adoption of its unique, programmable insulin pump and the launch of Amgen's (AMGN) Neulasta On-Body Delivery System.
April 7, 2015
12:56 EDTPODDPrimecap reports 5.02% passive stake in Insulet

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use